FTSE 100 news / Companies and sectors / Rentokil Initial
Rentokil Initial news analysis
Rentokil Initial (LSE: RTO) is in the FTSE 100. 16 of the last 21 days had relevant coverage.
Latest: Tuesday 20 October 2026
−3.3 from 4 relevant stories. Coverage mainly focused on US pricing pressure and the way AI is reshaping the pest-control market, which leans negative for Rentokil. A smaller offsetting piece covered its reset of North America for growth.
Tone over time
Coverage of Rentokil Initial improved between 30 September 2026 and 20 October 2026
Daily news tone, from −10 (clearly bad) to +10 (clearly good). Gaps are days with no relevant stories.
Tone rose 66% from −10 to −3 between 30 Sep and 20 Oct. Its high was 8 in 6 Oct.
- 11
- 22
- 33
8 days of 16 had fewer than 3 relevant stories, so those points are thin evidence. Numbered markers are the days with the strongest single headline (key below). This is the tone of coverage, not a share price.Source: MarketFrame news analysis
| day | Tone |
|---|---|
| 30 Sep | −10 |
| 1 Oct | – |
| 2 Oct | – |
| 3 Oct | −2 |
| 4 Oct | 5 |
| 5 Oct | −1 |
| 6 Oct | 8 |
| 7 Oct | 6 |
| 8 Oct | 3 |
| 9 Oct | −5 |
| 10 Oct | −1 |
| 11 Oct | – |
| 12 Oct | – |
| 13 Oct | −6 |
| 14 Oct | – |
| 15 Oct | −6 |
| 16 Oct | −4 |
| 17 Oct | 5 |
| 18 Oct | 5 |
| 19 Oct | 7 |
| 20 Oct | −3 |
Day by day
| Day | Tone | Stories | What the coverage was about |
|---|---|---|---|
| Tuesday 20 October 2026 | −3.3 | 4 | Coverage mainly focused on US pricing pressure and the way AI is reshaping the pest-control market, which leans negative for Rentokil. |
| Monday 19 October 2026 | +6.5 | 2 | Coverage was mainly about Jefferies reaffirming its Buy rating and keeping its 370p target on Rentokil Initial. |
| Sunday 18 October 2026 | +5.3 | 1 | Coverage was a single valuation piece on Rentokil's half-year results, which says the shares could be 32% below fair value. |
| Saturday 17 October 2026 | +5.0 | 3 | Coverage centred on analyst views, with Jefferies reaffirming its Buy rating and a consensus target price being reported. |
| Friday 16 October 2026 | −3.8 | 3 | Coverage was mainly about analysts trimming price targets, with UBS cutting its target while keeping a Buy rating and BofA lowering its target to 415p. |
| Thursday 15 October 2026 | −6.3 | 2 | Coverage leaned negative, with one piece looking at the share price slide and bearish views, and another on legal risks linked to the Terminix deal in California. |
| Wednesday 14 October 2026 | – | 0 | |
| Tuesday 13 October 2026 | −5.8 | 4 | Coverage centred on Bank of America cutting its price target on Rentokil, with slower growth cited, and on the shares sliding to the bottom of the FTSE 100. |
| Monday 12 October 2026 | – | 0 | |
| Sunday 11 October 2026 | – | 0 | |
| Saturday 10 October 2026 | −1.3 | 1 | Coverage was a single piece noting that Rentokil Initial's shares fell even though its profit rose. |
| Friday 9 October 2026 | −5.2 | 3 | Coverage centred on Rentokil's shares sliding to a multi-year low, ahead of an update on 22 October. |
| Thursday 8 October 2026 | +3.0 | 1 | Coverage centred on Rentokil selling SOLitude to Bain Capital, which is a straightforward disposal and leans mildly positive. |
| Wednesday 7 October 2026 | +6.3 | 1 | The only substantive coverage was a report of 4.5 percent first half revenue growth, which leans modestly positive. |
| Tuesday 6 October 2026 | +8.0 | 6 | Coverage was mainly about Stifel upgrading Rentokil to 'buy' from 'hold', with the broker citing a decade-low valuation. |
| Monday 5 October 2026 | −0.5 | 3 | Coverage centred on Rentokil's share price, with small daily gains in two items. |
| Sunday 4 October 2026 | +4.7 | 1 | Coverage noted Rentokil's shares rose 1.11 percent as analysts reset their price targets. |
| Saturday 3 October 2026 | −1.7 | 1 | The only relevant coverage reports Morgan Stanley cutting its price target on Rentokil, while the shares still gained 2.01 percent. |
| Friday 2 October 2026 | – | 0 | |
| Thursday 1 October 2026 | – | 0 | |
| Wednesday 30 September 2026 | −9.7 | 7 | Coverage centred on a Morgan Stanley downgrade to Equalweight with a lower price target, citing tougher US pest-control competition. |
Sector: Industrials and support services